Article Information
History
- September 28, 2020.
Article Versions
- Version 1 (August 26, 2020 - 05:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Laith J. Abu Raddad, PhD1,2,3,*,a,
- Hiam Chemaitelly, MSc1,2,
- Joel A. Malek, PhD4,5,
- Ayeda A. Ahmed, BSc4,
- Yasmin A. Mohamoud, MSc4,
- Shameem Younuskunju, MSc4,
- Houssein H. Ayoub, PhD5,
- Zaina Al Kanaani, PhD6,
- Abdullatif Al Khal, MD6,
- Einas Al Kuwari, MD6,
- Adeel A. Butt, MBBS MS6,
- Peter Coyle, MD6,
- Andrew Jeremijenko, MD6,
- Anvar Hassan Kaleeckal, MSc6,
- Ali Nizar Latif, MD6,
- Riyazuddin Mohammad Shaik, MSc6,
- Hanan F. Abdul Rahim, PhD7,
- Hadi M. Yassine, PhD8,9,
- Mohamed G. Al Kuwari, MD10,
- Hamad Eid Al Romaihi, MD11,
- Sheikh Mohammad Al Thani, MD11 and
- Roberto Bertollini, MD11
- 1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
- 2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
- 3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
- 4Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
- 5Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
- 5Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar
- 6Hamad Medical Corporation, Doha, Qatar
- 7College of Health Sciences, QU Health, Qatar University, Doha, Qatar
- 8Biomedical Research Center, Qatar University, Doha, Qatar
- 9Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
- 10Primary Health Care Corporation, Doha, Qatar
- 11Ministry of Public Health, Doha, Qatar
- ↵aCorresponding author; email: lja2002{at}qatar-med.cornell.edu
↵* Address reprints requests or correspondence to Professor Laith J. Abu-Raddad, Infectious Disease Epidemiology Group, World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar. Telephone: +(974) 4492-8321. Fax: +(974) 4492-8333.
Posted September 28, 2020.
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
